# Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

> clinical trial · VERIFIED · 2026-07-29

Status: ACTIVE_NOT_RECRUITING · Sponsor: Gilead Sciences · Condition: Endometrial Cancer

- Company: Gilead Sciences
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06486441

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.